Edition:
United Kingdom

Cytori Therapeutics Inc (CYTX.OQ)

CYTX.OQ on NASDAQ Stock Exchange Capital Market

0.31USD
15 Jan 2019
Change (% chg)

-- (--)
Prev Close
$0.31
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
100,286
52-wk High
$5.14
52-wk Low
$0.25

Latest Key Developments (Source: Significant Developments)

Cytori Therapeutics Says Co Entered Into An Amendment To Its Existing Loan And Security Agreement, Dated May 29, 2015
Wednesday, 2 Jan 2019 

Jan 2 (Reuters) - Cytori Therapeutics Inc ::CYTORI THERAPEUTICS SAYS ON DEC. 31, ENTERED INTO AN AMENDMENT TO ITS EXISTING LOAN AND SECURITY AGREEMENT, DATED MAY 29, 2015 - SEC FILING.CYTORI THERAPEUTICS INC - AS PER AMENDMENT OXFORD AND LENDERS AGREED TO EXTEND MATURITY DATE FROM JUNE 1, 2019 TO JUNE 1, 2020.CYTORI THERAPEUTICS INC - AMENDMENT ALSO INCREASES MINIMUM LIQUIDITY COVENANT LEVEL FROM $1.5 MILLION TO $2.0 MILLION.CYTORI THERAPEUTICS INC - AMENDMENT EXTENDS INTEREST-ONLY PERIOD UNDER LOAN AGREEMENT TO MARCH 1, 2019.  Full Article

Cytori Therapeutics Files Prospectus Relates To Offer, Sale Of Co's Stock
Friday, 21 Sep 2018 

Sept 21 (Reuters) - Cytori Therapeutics Inc ::CYTORI THERAPEUTICS FILES PROSPECTUS RELATES TO OFFER, SALE OF UP TO 3.7 MILLION SHARES OF CO'S COMMON STOCK BY LINCOLN PARK CAPITAL FUND LLC - SEC FILING.  Full Article

Cytori Therapeutics Enters Agreement With B. Riley FBR To Sell Its Shares
Friday, 1 Jun 2018 

June 1 (Reuters) - Cytori Therapeutics Inc ::CYTORI THERAPEUTICS INC - ON JUNE 1, ENTERED SALES AGREEMENT WITH B. RILEY FBR TO SELL ITS SHARES WITH AGGREGATE OFFERING PRICE OF UP TO $6.5 MILLION.  Full Article

Swissquote Bank SA Reports 12 pct Passive Stake In Cytori Therapeutics As Of Dec. 29, 2017
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Cytori Therapeutics Inc ::SWISSQUOTE BANK SA REPORTS 12 PERCENT PASSIVE STAKE IN CYTORI THERAPEUTICS INC AS OF DECEMBER 29, 2017 - SEC FILING‍​.  Full Article

Cytori Therapeutics Inc ‍announces new investigator initiated U.S. clinical trial for hip osteonecrosis​
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Cytori Therapeutics Inc :Cytori Therapeutics Inc - ‍announced a new investigator initiated U.S. clinical trial for hip osteonecrosis​.  Full Article

Cytori reports Q3 loss per share $0.14
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Cytori Therapeutics Inc :Cytori reports third quarter 2017 business and financial results.Q3 loss per share $0.14.Cytori Therapeutics Inc - ‍received U.S. FDA IDE approval for relief, a thermal burn pilot trial related to ongoing barda contract​.Cytori Therapeutics Inc - ‍expects full year 2017 operating cash burn to be lower than 2016, primarily due to restructuring announced in September 2017​.  Full Article